Related Experiment Video
Updated: Jul 4, 2026
14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Biomarker discovery in psychiatric disorders.
1Institute of Biotechnology, University of Cambridge, Cambridge, UK.
Electrophoresis
|June 3, 2008
Summary
Schizophrenia research needs larger sample sizes for biomarker discovery due to its complexity. Multi-omics approaches and advanced technologies are key to understanding this neuropsychiatric disorder at a molecular level.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Schizophrenia is a complex neuropsychiatric disorder with diverse genetic, developmental, and environmental causes.
- Patient heterogeneity and disease complexity hinder biomarker discovery for schizophrenia.
- A deeper molecular understanding is crucial for effective diagnosis and treatment.
Purpose of the Study:
- To review challenges in psychiatric disorder biomarker discovery, emphasizing the need for large sample sizes.
- To discuss the application of multi-omics profiling for identifying molecular signatures and patient subgroups in schizophrenia.
- To explore the potential of mass spectrometry (MS)-based proteomics and emerging technologies in schizophrenia research.
Main Methods:
- Review of current literature on biomarker discovery challenges in psychiatric disorders.
- Analysis of multi-omics profiling strategies for large-scale patient sample analysis.
- Evaluation of MS-based protein profiling studies and technological advancements in schizophrenia research.
Main Results:
- Large sample numbers are essential to overcome heterogeneity and complexity in schizophrenia biomarker discovery.
- Multi-omics approaches offer a powerful strategy to identify disease-specific molecular signatures and patient subgroups.
- MS-based proteomics and new technologies show promise for advancing schizophrenia research.
Conclusions:
- Addressing the challenges in schizophrenia biomarker discovery requires large-scale, multi-omics studies.
- Technological advancements are critical for uncovering the molecular underpinnings of schizophrenia.
- Future research should leverage these approaches to improve patient stratification and therapeutic strategies.
Related Concept Videos
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...